SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Rapid antidepressant effects associated with ketamine have shifted the landscape for the

Molecular mechanisms underlying the antidepressant actions of

PDF) Does mismatch negativity have utility for NMDA receptor drug

PDF) Changing prevalence and treatment of depression among older

Ketamine and Other NMDA Antagonists: Early Clinical Trials and

Frontiers Drugs Based on NMDAR Hypofunction Hypothesis in

Molecular mechanisms underlying the antidepressant actions of

PDF) Neuroprogression in schizophrenia: Pathways underpinning

PDF) Does mismatch negativity have utility for NMDA receptor drug

SciELO - Brasil - Estudos traducionais de neuropsiquiatria e